These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10377513)

  • 21. Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.
    Wagner JA; Messner AH; Moran ML; Daifuku R; Kouyama K; Desch JK; Manley S; Norbash AM; Conrad CK; Friborg S; Reynolds T; Guggino WB; Moss RB; Carter BJ; Wine JJ; Flotte TR; Gardner P
    Laryngoscope; 1999 Feb; 109(2 Pt 1):266-74. PubMed ID: 10890777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Lee T; Southern KW
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005599. PubMed ID: 17443603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene transfer for cystic fibrosis.
    Welsh MJ
    J Clin Invest; 1999 Nov; 104(9):1165-6. PubMed ID: 10545512
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficiency of cationic lipid-mediated transfection of polarized and differentiated airway epithelial cells in vitro and in vivo.
    Jiang C; O'Connor SP; Fang SL; Wang KX; Marshall J; Williams JL; Wilburn B; Echelard Y; Cheng SH
    Hum Gene Ther; 1998 Jul; 9(11):1531-42. PubMed ID: 9694152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on gene therapy for cystic fibrosis.
    Griesenbach U; Geddes DM; Alton EW
    Curr Opin Mol Ther; 2003 Oct; 5(5):489-94. PubMed ID: 14601517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward cystic fibrosis gene therapy.
    Wagner JA; Gardner P
    Annu Rev Med; 1997; 48():203-16. PubMed ID: 9046956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis.
    Noone PG; Hohneker KW; Zhou Z; Johnson LG; Foy C; Gipson C; Jones K; Noah TL; Leigh MW; Schwartzbach C; Efthimiou J; Pearlman R; Boucher RC; Knowles MR
    Mol Ther; 2000 Jan; 1(1):105-14. PubMed ID: 10933918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis.
    Crystal RG; Mastrangeli A; Sanders A; Cooke J; King T; Gilbert F; Henschke C; Pascal W; Herena J; Harvey BG
    Hum Gene Ther; 1995 May; 6(5):667-703. PubMed ID: 7578402
    [No Abstract]   [Full Text] [Related]  

  • 29. Prospects for gene therapy for cystic fibrosis.
    Davies JC; Geddes DM; Alton EW
    Mol Med Today; 1998 Jul; 4(7):292-9. PubMed ID: 9743990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moving forward: cystic fibrosis gene therapy.
    Griesenbach U; Alton EW
    Hum Mol Genet; 2013 Oct; 22(R1):R52-8. PubMed ID: 23918661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges facing microRNA therapeutics for cystic fibrosis lung disease.
    De Santi C; Greene CM
    Epigenomics; 2020 Feb; 12(3):179-181. PubMed ID: 32011168
    [No Abstract]   [Full Text] [Related]  

  • 32. [On the way to gene therapy in cystic fibrosis].
    Norek A; Bal J
    Med Wieku Rozwoj; 2006; 10(1 Pt 2):247-74. PubMed ID: 17028392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis.
    Zabner J; Couture LA; Gregory RJ; Graham SM; Smith AE; Welsh MJ
    Cell; 1993 Oct; 75(2):207-16. PubMed ID: 7691415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cationic lipid formulations for intracellular gene delivery of cystic fibrosis transmembrane conductance regulator to airway epithelia.
    Cheng SH; Marshall J; Scheule RK; Smith AE
    Methods Enzymol; 1998; 292():697-717. PubMed ID: 9711593
    [No Abstract]   [Full Text] [Related]  

  • 35. The pathogenesis of cystic fibrosis and progress towards gene therapy.
    Stern M; Alton E
    J R Coll Physicians Lond; 1999; 33(5):434-9. PubMed ID: 10624657
    [No Abstract]   [Full Text] [Related]  

  • 36. Cystic fibrosis gene therapy: the first trial.
    Arch Dis Child; 2015 Sep; 100(9):844. PubMed ID: 26205882
    [No Abstract]   [Full Text] [Related]  

  • 37. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.
    Zabner J; Ramsey BW; Meeker DP; Aitken ML; Balfour RP; Gibson RL; Launspach J; Moscicki RA; Richards SM; Standaert TA
    J Clin Invest; 1996 Mar; 97(6):1504-11. PubMed ID: 8617884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bad for cats, good for humans? Modified feline immunodeficiency virus for gene therapy.
    Crystal RG
    J Clin Invest; 1999 Dec; 104(11):1491-3. PubMed ID: 10587510
    [No Abstract]   [Full Text] [Related]  

  • 39. Gene therapy for cystic fibrosis.
    Davies JC; Alton EW
    Proc Am Thorac Soc; 2010 Nov; 7(6):408-14. PubMed ID: 21030522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term therapeutic and reporter gene expression in lentiviral vector treated cystic fibrosis mice.
    Cmielewski P; Donnelley M; Parsons DW
    J Gene Med; 2014; 16(9-10):291-9. PubMed ID: 25130650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.